Navigation Links
ClinOps Announces Appointment of New President and CEO
Date:10/25/2010

SAN FRANCISCO, Oct. 25 /PRNewswire/ -- ClinOps, LLC (formerly Pacific Data Designs) today announced that David Herron has been appointed to the organization as president and chief executive officer.  In addition, David has been named to ClinOps' Board of Directors.  

"David is well equipped to lead this company into the next phase of its maturity.  His global sales experience, business relationships and operational leadership are fundamentally important to ClinOps growth over the next five years.  David brings tremendous knowledge of professional and technical healthcare services with extensive emphasis on clients, quality and operations," said ClinOps Chairman, Rod Boone.  "David is a proven executive, focused on driving business results."

Prior to joining ClinOps, Mr. Herron held a number of leadership positions at SYNARC, the world's largest central imaging lab, most recently as Chief Operating Officer.  Mr. Herron has also held senior management positions at Webify Solutions (acquired by IBM), Vitria Technology and Health Net.  He is a seventeen-year veteran of the US military serving in the US Marine Corps and as an Adjutant General and Logistics Officer.  He was thrice decorated during Operations Desert Shield & Storm.  He is a distinguished graduate of Lipscomb and Vanderbilt universities.

The ClinOps Board of Directors is confident the combination of David's experience and passion will lead to continued growth and superior services for ClinOps customers.

About ClinOpsClinOps, LLC is a streamlined contract research organization that focuses on understanding and fulfilling each customer's needs and delivering top-quality results within aggressive timelines.  We specialize in four critical service areas: Clinical Operations, Data Management, Biostatistics and Data Rescue Services at www.clinops.com.Media Contact:Natalie Cummins908 209 7726
'/>"/>

SOURCE ClinOps, LLC
Copyright©2010 PR Newswire.
All rights reserved

Related biology news :

1. Aware, Inc. Announces Q310 Earnings Conference Call
2. NYSCF announces 2010 NYSCF Investigators
3. Onconova announces FDA agreement of a SPA for a pivotal phase 3 trial of Estybon in MDS
4. Penn Vet announces $100,000 winners of 2010 World Leadership Award and Student Inspiration Awards
5. TERMIS-North America announces speakers for annual event
6. American Society of Agronomy announces the class of 2010 Fellows
7. American Society of Agronomy announces award recipients
8. Biophysical Society announces 2011 society fellows
9. ActiveCare, Inc. Announces Capital Raise Commitment and Balance Sheet Restructuring
10. BIO-key® Announces Second Quarter 2010 Earnings Release and Conference Call Schedule
11. The American Ceramic Society announces 2010 Distinguished Life Members and class of Fellows
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/13/2017)... -- Former 9/11 Commission border counsel and Special Counsel ... of Identity Strategy Partners, LLP, today releases the ... Order: Protecting the Nation From Foreign Terrorist Entry Into ... President Trump,s ,Travel Ban, Executive Order gains more notoriety ... travel ban, it is important that our national discourse ...
(Date:2/8/2017)... 2017 Report Highlights ... The global synthetic-biology market reached nearly ... 2021, growing at a compound annual growth rate (CAGR) of ... the global markets for synthetic biology. - Analyses of global ... projections of compound annual growth rates (CAGRs) through 2021. - ...
(Date:2/7/2017)... York , February 7, 2017 ... ID Global Solutions Corporation [OTC: IDGS], ("Ipsidy" or the ... and electronic transaction processing services, is pleased to announce ... the Company. Effective January 31, 2017, ... Board of Directors, CEO and President.  An experienced payment ...
Breaking Biology News(10 mins):
(Date:2/16/2017)... 16, 2017 Research and Markets ... Global Markets" report to their offering. ... ... biobrick parts, delivery plasmids, chassis organisms, synthetic cells, production ... genome editing, bioinformatics and specialty media) and enabled technologies ...
(Date:2/16/2017)... 16, 2017 Patient Care ... innovative telemedicine application, new and leading edge therapies ... a boom worldwide. The healthcare sector as whole ... services and new therapies for companies such as ... Cellectar Biosciences, Inc. (NASDAQ: CLRB ), ...
(Date:2/16/2017)... N.J. , Feb. 16, 2017  Champions Oncology, ... in the development and sale of advanced technology solutions ... oncology drugs, today announced the addition of new cohorts ... These new models will expand Champions, product line ... head and neck cancer, AML, and non-small cell lung ...
(Date:2/16/2017)... Feb. 16, 2017  Rhythm, a biopharmaceutical ... deficiencies that result in life-threatening metabolic disorders, ... million mezzanine round of financing with existing ... Capital, New Enterprise Associates, Pfizer Venture Investments, ... healthcare investment fund. Rhythm will use the ...
Breaking Biology Technology: